Gluten Free Travel-US Organizes Gluten Free Trips and Customized Itineraries for Individuals
Butterfly Bakery Offers Wonderful Gluten-Free and Sugar-Free Treats

Take a Moment to Complete NFCA's Survey of Gluten in Medications

Screen Shot 2012-01-10 at 4.03.26 PMLast November, the National Foundation for Celiac Awareness (NFCA) announced that it would conduct a first-of-its-kind research study on gluten in medications, funded by the U.S. Food and Drug Administration (FDA). NFCA, partnering with St. John's University College of Pharmacy and Allied Health Professions, is conducting this research in two parts. The first part of the study is happening now: a survey of the Celiac and gluten sensitive populations.

NFCA urges all people who are following a gluten-free diet to participate. Participants will be asked about their experiences taking medicine. They will also be asked to share information if they think they might have had a gluten-related reaction to an over-the-counter or prescription medicine. Results from the survey will guide the second phase of the study: our team will test some of the medicines identified in the survey to see if they contain gluten.

This critically needed preliminary research aims to validate or nullify the anecdotal adverse experiences associated with gluten in medications that have been reported by people with Celiac disease and gluten sensitivity. It is a first step to determine if more investigation is needed, which may lead to additional research, labeling, and safe use guideline initiatives. More information about the Safe Use Initiative can be found at www.fda.gov/safeuseinitiative

The NFCA is looking to generate as MANY responses as possible to strengthen their research. They need YOUR help in this effort. We ask that you circulate this message and invite all those who are gluten-free to complete the survey on their website. The survey takes between 4-15 minutes to complete. It closes on February 28, 2012.

Thanks so much for your support of this crucial research study.

 

Comments